Analyst Reco. Nyxoah SA

Equities

NYXH

BE0974358906

Real-time Euronext Bruxelles Other stock markets 03:00:07 2024-04-30 am EDT			5-day change	1st Jan Change
10.45 ^EUR	+0.97%		+6.63%	+145.31%

Apr. 12	Nyxoah Names New Chief Medical Officer	MT
Apr. 12	Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Adjusts Nyxoah's Price Target to $27 From $20, Keeps Buy Rating	Mar. 20	MT
HC Wainwright Raises Nyxoah Price Target to $22 From $18, Maintains Buy Rating	Mar. 20	MT
Oppenheimer Adjusts Nyxoah Price Target to $20 From $17, Maintains Outperform Rating	Mar. 14	MT
Piper Sandler Raises Nyxoah's Price Target to $20 From $15, Maintains Overweight Rating	Mar. 06	MT
Oppenheimer Adjusts Nyxoah Price Target to $17 From $12, Maintains Outperform Rating	Mar. 06	MT
Stifel Raises Price Target on Nyxoah to $20 From $10, Maintains Buy Rating	Mar. 05	MT
Cantor Fitzgerald Adjusts Price Target on Nyxoah to $14 From $10, Maintains Overweight Rating	Feb. 09	MT
Stifel Cuts Nyxoah's Price Target to $10 From $14, Keeps Buy Rating	Nov. 07	MT
HC Wainwright Initiates Nyxoah With Buy Rating, $15 Price Target	23-07-31	MT
Cantor Fitzgerald Adjusts Price Target on Nyxoah to $12 From $17, Keeps Overweight Rating	23-05-18	MT
Stifel Adjusts Price Target on NYXH to $15 From $16, Maintains Buy Rating	23-05-17	MT
Piper Sandler Adjusts Price Target on Nyxoah to $12 From $13, Maintains Overweight Rating	23-05-17	MT
Stifel Nicolaus Adjusts Nyxoah Price Target to $16 From $19, Maintains Buy Rating	23-03-23	MT
Oppenheimer Adjusts Nyxoah Price Target to $15 From $30, Maintains Outperform Rating	22-11-09	MT
Piper Sandler Adjusts Price Target on Nyxoah to $20 From $30, Reiterates Overweight Rating	22-08-09	MT
NYXOAH : Cantor Fitzgerald Starts Nyxoah SA at Overweight With $43 Price Target	21-07-28	MT
NYXOAH : Piper Sandler Starts Nyxoah SA at Overweight With $40 Price Target	21-07-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer